Financhill
Back

Ultragenyx Pharmaceutical Vs. Apellis Pharmaceuticals Industry Stock Comparison

Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
45.15
Seasonality Move:
-7.5%
Sell
36

APLS
Apellis Pharmaceuticals

Last Price:
39.55
Seasonality Move:
-17.52%
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $45.14. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Apellis Pharmaceuticals (APLS) is a Sell

Is Apellis Pharmaceuticals a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals [APLS] share price is $39.53. The Score for APLS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • APLS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $45.14
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

APLS Stock Price Chart

What is Apellis Pharmaceuticals's stock price today?

  • The Apellis Pharmaceuticals share price today is $39.53
    The current trend is relatively stagnant and APLS is experiencing slight selling pressure.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.62 Buy
Relative Strength Index (14 RSI): 66.39 Buy
Chaikin Money Flow: 779842 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.34 - 42.98) Buy
Bollinger Bands (100): (40.31 - 48.45) Buy

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.06 Sell
Relative Strength Index (14 RSI): 50.82 Buy
Chaikin Money Flow: -669894 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (37.09 - 41.59) Buy
Bollinger Bands (100): (39.51 - 58.55) Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.16 Buy
20-day SMA: 40.88 Buy
50-day SMA: 41.15 Buy
200-day SMA: 42.67 Buy
8-day EMA: 42.68 Buy
20-day EMA: 41.65 Buy
50-day EMA: 41.88 Buy
200-day EMA: 43.2 Buy

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 37.13 Buy
20-day SMA: 38.76 Buy
50-day SMA: 40.93 Sell
200-day SMA: 52.15 Sell
8-day EMA: 38.09 Buy
20-day EMA: 38.71 Buy
50-day EMA: 41.81 Sell
200-day EMA: 50.68 Sell

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.87 per share, an increase next quarter of $0.32 per share, an increase this year of $3.51 per share, and an increase next year of $2.00 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apellis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):